HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anti-hypertensive therapy in pregnancy-induced hypertension with urapidil].

Abstract
Urapidil is an antagonist of postsynaptic alpha 1 receptors, which leads to a diminution of the increased blood pressure by reducing the peripheral vascular resistance. With this pilot study we examined, whether it is possible to reduce the pregnancy-induced-hypertension with urapidil postpartum. The postpartum dosage of dihydralazine was diminished step by step and finally discontinued. We started i.v. treatment with urapidil at a diastolic blood pressure of more than 100 mm Hg. We observed a declining blood pressure in all cases without any tachycardia or serious side effects. Further studies will have to classify the rank of urapidil in the treatment of hypertension in preeclampsia.
AuthorsJ Wacker, J Müller, E M Grischke, R Unkels, G Bastert
JournalZentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 116 Issue 5 Pg. 271-3 ( 1994) ISSN: 0044-4197 [Print] Germany
Vernacular TitleAntihypertensive Therapie bei schwangerschaftsinduzierter Hypertonie (SIH) mit Urapidil.
PMID8023622 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antihypertensive Agents
  • Piperazines
  • urapidil
  • Dihydralazine
Topics
  • Antihypertensive Agents (adverse effects, therapeutic use)
  • Blood Pressure (drug effects)
  • Blood Pressure Monitors
  • Dihydralazine (therapeutic use)
  • Drug Administration Schedule
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Hypertension (drug therapy)
  • Infusions, Intravenous
  • Maternal-Fetal Exchange (drug effects)
  • Pilot Projects
  • Piperazines (adverse effects, therapeutic use)
  • Pre-Eclampsia (drug therapy)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (drug therapy)
  • Puerperal Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: